Interdisciplinary perspectives on the co-management of metabolic dysfunction-associated steatotic liver disease and coronary artery disease
Year: 2024
Type: review
Institutions: Geisinger Medical Center, Barcelona Institute for Global Health, CUNY Graduate School of Public Health and Health Policy, Universitat de Barcelona, University of Dundee, Ninewells Hospital, Virginia Commonwealth University, Virginia Commonwealth University Medical Center, Ospedale Sacro Cuore Don Calabria, National University of Malaysia, Aga Khan University, Baylor College of Medicine, Ochsner Health System, Ochsner Medical Center, Emory University, Pontificia Universidad Católica de Chile, University of Florida Health, University of Florida, NYU Langone Health, New York University
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: U.S. Department of Veterans Affairs, Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, Siemens USA, American Association for the Study of Liver Diseases, Gilead Sciences, UK Research and Innovation, South Dakota Governor's Office of Economic Development, Moderna, National Institute for Health and Care Research, British Heart Foundation, European Commission, Novo Nordisk, European Association for the Study of the Liver, National Institutes of Health, Medical Research Council
Award: G5204603102
OpenAlex ID: W4405269072